| Today, Mon, Nov 9, 2009 | | | Ask Your Doctor If This Ad Is Right for You at BusinessWeek (Mon 5:01pm)
| | | A Big Upgrade for Gilead Sciences at Motley Fool (Mon 1:31pm)
| | | FDA delays review of GlaxoSmithKline pain drug at bizjournals.com (Mon 11:05am)
| | | Xoma Waffles on Timing of Drug Partnership: BioBuzz at TheStreet.com (Mon 10:23am)
| | | FDA extends review of XenoPort-Glaxo pain drug AP (Mon 8:39am)
| | | 5-Star Stocks Poised to Pop: Gilead Sciences at Motley Fool (Mon 8:13am)
| | | Ariad Upgraded, Xenoport Drug Delayed: BioBuzz at TheStreet.com (Mon 7:51am)
| | | AstraZeneca lifted to buy, Roche cut to hold: RBS at MarketWatch (Mon 3:53am)
| | | AstraZeneca downgraded to underweight at JP Morgan at MarketWatch (Mon 3:21am)
| | Sat, Nov 7, 2009 | | | Santarus Reports Strong Quarter Zacks.com (Sat, Nov 7)
| | Fri, Nov 6, 2009 | | | GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010 Business Wire (Fri, Nov 6)
| | | No Product Revenues, Plenty of Risk: Buy Exelixis? at CNBC (Fri, Nov 6)
| | | The Downside of Dollar-Cost Averaging at Motley Fool (Fri, Nov 6)
| | | Oculus, Bianco and Cel-Sci Oh My!: BioBuzz at TheStreet.com (Fri, Nov 6)
| | | Biosimilars, Biologics, Biotech And Specialty Pharmaceuticals: Piper Jaffray Picks The Stocks And Sectors With Highest Potential Returns For Investors Wall Street Transcript (Fri, Nov 6)
| | | BioCryst Competition for IV Flu Drug: BioBuzz at TheStreet.com (Fri, Nov 6)
| | | The Top 4 Healthcare Dividend Stocks: Covered Call Trades at Seeking Alpha (Fri, Nov 6)
| | Thu, Nov 5, 2009 | | | Rail Worker Killed as Strike Snarls Philadelphia at The Wall Street Journal Online (Thu, Nov 5)
| | | Slow Down There, Merck at Motley Fool (Thu, Nov 5)
| | | Placing Bets On Human Genome's Benlysta Indie Research (Thu, Nov 5)
| Add GSK News to My Yahoo!:

| |
|